AIMC Topic: Cognitive Dysfunction

Clear Filters Showing 11 to 20 of 613 articles

Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study.

Neurology
BACKGROUND AND OBJECTIVES: The choroid plexus (ChP) plays a crucial role in maintaining brain health. Alzheimer disease (AD) pathologies may damage the ChP and accelerate neurodegeneration. Previous imaging studies have found overall increased ChP vo...

Using machine learning for detection of Parkinson's disease and mild cognitive impairment.

PloS one
BACKGROUND: Parkinson's disease is a movement disorder featuring motor symptoms and cognitive decline, which can manifest as mild cognitive impairment. The incidence of mild cognitive impairment increases with disease progression, and Parkinson's dis...

Multi-marker discovery for mild cognitive impairment in metabolomics using machine learning with a global surrogate model via partial least squares.

Metabolomics : Official journal of the Metabolomic Society
INTRODUCTION: Dementia can be prevented through early intervention; hence, there is an urgent need for biomarkers to help diagnose mild cognitive impairment (MCI).

Hemodynamic determinants of postoperative neurocognitive impairment using Random Forest analysis and partial dependence plots.

Scientific reports
This study investigated the effect of hemodynamic data during cardiopulmonary bypass (CPB) on neurocognitive impairment in patients undergoing coronary artery bypass graft (CABG) surgery using machine learning algorithms. Twenty-eight CABG patients w...

Assessing the accuracy of survival machine learning and traditional statistical models for Alzheimer's disease prediction over time: a study on the ADNI cohort.

BMC medical research methodology
BACKGROUND: Mild cognitive impairment (MCI) represents a transitional stage to Alzheimer's disease (AD), making progression prediction crucial for timely intervention. Predictive models integrating clinical, laboratory, and survival data can enhance ...

Brain-derived 5-hydroxymethylcytosine epigenetic scores are related to Alzheimer's disease pathology and cognitive decline.

Acta neuropathologica
BACKGROUND: Cytosine modifications play critical roles in gene regulation and disease pathogenesis. Elucidating novel epigenetic contributions to Alzheimer's disease (AD) could advance diagnostic, prognostic, and therapeutic strategies. 5-hydroxymeth...

Dual-task walking for early detection of Alzheimer's disease: comparative analysis of tasks using whole-body gait variables.

BMC geriatrics
BACKGROUND: The worldwide rise in dementia creates an urgent need for screening methods that are both sensitive and easy to administer. Dual-task walking-requiring people to walk while performing a second cognitive or motor task-meets these criteria ...

Screening mild cognitive impairment using aspects of personal, social, and functional lifestyle: Machine Learning Approaches.

PloS one
OBJECTIVE: Mild cognitive impairment (MCI) signals cognitive decline beyond normal aging and increases dementia risk. Early identification enables preventative interventions, yet many patients in primary care go undetected. This study examines whethe...

Multimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer's disease.

NeuroImage
Alzheimer's disease (AD), the most prevalent neurodegenerative disorder, is marked by the accumulation of amyloid-β (Aβ) plaques. Although cerebral Aβ positron emission tomography (Aβ-PET) remains the gold standard for assessing cerebral Aβ burden, i...

Disruption of low-frequency narrowband EEG microstate networks in Parkinson's disease with mild cognitive impairment.

Journal of neuroengineering and rehabilitation
BACKGROUND: Electroencephalogram (EEG) microstates provide insights into large-scale brain network coordination, revealing distinct neural dynamics within specific frequency bands associated with cognitive processes and neurological disorders. Critic...